Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype

Research output: Chapter in Book/Report/Conference proceedingChapter

13 Citations (Scopus)

Abstract

The purpose of this article is to provide a critical review of the molecular alterations in pancreatic cancer that are clinically investigated as therapeutic targets and their potential impact on clinical outcomes. Adenocarcinoma of exocrine pancreas is generally associated with poor prognosis and the conventional therapies are marginally effective. Advances in understanding the genetic regulation of normal and neoplastic development of pancreas have led to development and clinical evaluation of new therapeutic strategies that target the signaling pathways and molecular alterations in pancreatic cancer. Applications have begun to utilize the genetic targets as biomarkers for prediction of therapeutic responses and selection of treatment options. The goal of accomplishing personalized tumor-specific therapy with tolerable side effects for patients with pancreatic cancer is hopefully within reach in the foreseeable future.

Original languageEnglish (US)
Title of host publicationImpact of Genetic Targets on Cancer Therapy
EditorsWafik El-Deiry
Pages91-143
Number of pages53
DOIs
StatePublished - Feb 15 2013

Publication series

NameAdvances in Experimental Medicine and Biology
Volume779
ISSN (Print)0065-2598

Fingerprint

Biomarkers
Pancreatic Neoplasms
Tumors
Phenotype
Therapeutics
Exocrine Pancreas
Pancreas
Adenocarcinoma
Neoplasms

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Yee, N. S-S. (2013). Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype. In W. El-Deiry (Ed.), Impact of Genetic Targets on Cancer Therapy (pp. 91-143). (Advances in Experimental Medicine and Biology; Vol. 779). https://doi.org/10.1007/978-1-4614-6176-0-5
Yee, Nelson Shu-Sang. / Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype. Impact of Genetic Targets on Cancer Therapy. editor / Wafik El-Deiry. 2013. pp. 91-143 (Advances in Experimental Medicine and Biology).
@inbook{3b1257e4d4d04529b8b78b3b31eabc3c,
title = "Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype",
abstract = "The purpose of this article is to provide a critical review of the molecular alterations in pancreatic cancer that are clinically investigated as therapeutic targets and their potential impact on clinical outcomes. Adenocarcinoma of exocrine pancreas is generally associated with poor prognosis and the conventional therapies are marginally effective. Advances in understanding the genetic regulation of normal and neoplastic development of pancreas have led to development and clinical evaluation of new therapeutic strategies that target the signaling pathways and molecular alterations in pancreatic cancer. Applications have begun to utilize the genetic targets as biomarkers for prediction of therapeutic responses and selection of treatment options. The goal of accomplishing personalized tumor-specific therapy with tolerable side effects for patients with pancreatic cancer is hopefully within reach in the foreseeable future.",
author = "Yee, {Nelson Shu-Sang}",
year = "2013",
month = "2",
day = "15",
doi = "10.1007/978-1-4614-6176-0-5",
language = "English (US)",
isbn = "9781461461753",
series = "Advances in Experimental Medicine and Biology",
pages = "91--143",
editor = "Wafik El-Deiry",
booktitle = "Impact of Genetic Targets on Cancer Therapy",

}

Yee, NS-S 2013, Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype. in W El-Deiry (ed.), Impact of Genetic Targets on Cancer Therapy. Advances in Experimental Medicine and Biology, vol. 779, pp. 91-143. https://doi.org/10.1007/978-1-4614-6176-0-5

Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype. / Yee, Nelson Shu-Sang.

Impact of Genetic Targets on Cancer Therapy. ed. / Wafik El-Deiry. 2013. p. 91-143 (Advances in Experimental Medicine and Biology; Vol. 779).

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype

AU - Yee, Nelson Shu-Sang

PY - 2013/2/15

Y1 - 2013/2/15

N2 - The purpose of this article is to provide a critical review of the molecular alterations in pancreatic cancer that are clinically investigated as therapeutic targets and their potential impact on clinical outcomes. Adenocarcinoma of exocrine pancreas is generally associated with poor prognosis and the conventional therapies are marginally effective. Advances in understanding the genetic regulation of normal and neoplastic development of pancreas have led to development and clinical evaluation of new therapeutic strategies that target the signaling pathways and molecular alterations in pancreatic cancer. Applications have begun to utilize the genetic targets as biomarkers for prediction of therapeutic responses and selection of treatment options. The goal of accomplishing personalized tumor-specific therapy with tolerable side effects for patients with pancreatic cancer is hopefully within reach in the foreseeable future.

AB - The purpose of this article is to provide a critical review of the molecular alterations in pancreatic cancer that are clinically investigated as therapeutic targets and their potential impact on clinical outcomes. Adenocarcinoma of exocrine pancreas is generally associated with poor prognosis and the conventional therapies are marginally effective. Advances in understanding the genetic regulation of normal and neoplastic development of pancreas have led to development and clinical evaluation of new therapeutic strategies that target the signaling pathways and molecular alterations in pancreatic cancer. Applications have begun to utilize the genetic targets as biomarkers for prediction of therapeutic responses and selection of treatment options. The goal of accomplishing personalized tumor-specific therapy with tolerable side effects for patients with pancreatic cancer is hopefully within reach in the foreseeable future.

UR - http://www.scopus.com/inward/record.url?scp=84873594890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873594890&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-6176-0-5

DO - 10.1007/978-1-4614-6176-0-5

M3 - Chapter

SN - 9781461461753

T3 - Advances in Experimental Medicine and Biology

SP - 91

EP - 143

BT - Impact of Genetic Targets on Cancer Therapy

A2 - El-Deiry, Wafik

ER -

Yee NS-S. Toward the goal of personalized therapy in pancreatic cancer by targeting the molecular phenotype. In El-Deiry W, editor, Impact of Genetic Targets on Cancer Therapy. 2013. p. 91-143. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-1-4614-6176-0-5